Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Cadrenal (CVKD) 10% Owner Pham Quang Sells Shares
What Happened
Pham Quang, a 10% owner of Cadrenal Therapeutics, sold a total of 4,126 shares in two open-market transactions under a Rule 10b5-1 plan. On 2026-06-16 he sold 3,613 shares at a weighted average price of $3.18 for $11,489 (F2). On 2026-06-17 he sold 513 shares at a weighted average price of $3.16 for $1,621 (F3). Combined proceeds were about $13,110. These transactions are sales (not purchases).
Key Details
- Transaction dates: 2026-06-16 (3,613 shares, WAP $3.18, total $11,489) and 2026-06-17 (513 shares, WAP $3.16, total $1,621).
- Price ranges: 6/16 sales occurred at prices between $3.04–$3.37 (F2); 6/17 sales between $3.14–$3.20 (F3). Reporting person can provide per-price breakdown on request.
- Plan/authorization: Shares sold pursuant to a Rule 10b5-1 trading plan adopted Sept 25, 2025 (F1).
- Ownership/authority: Pham is trustee of The PVBQ Living Trust and has sole voting and dispositive power over the trust’s shares; the trust’s sole beneficiary is his child (F4).
- Filing timing: Report filed 2026-06-18 covering 6/16–6/17 trades; this appears to be within the typical Section 16 filing window.
Context
- These were routine sales under a pre-established 10b5-1 plan; such plans allow insiders to sell on a schedule and reduce the inference that sales reflect new private information.
- Sales reduce insider holdings but do not, by themselves, indicate company performance or management view. No purchases, option exercises, or awards were reported in this filing.
Insider Transaction Report
Form 4
Pham Quang X
DirectorChairman and CEO10% Owner
Transactions
- Sale
Common Stock
[F1][F2]2026-06-16$3.18/sh−3,613$11,489→ 129,102 total - Sale
Common Stock
[F1][F3]2026-06-17$3.16/sh−513$1,621→ 128,589 total
Holdings
- 200,000(indirect: By Trust)
Common Stock
[F4]
Footnotes (4)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.04 through $3.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.14 through $3.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.
Signature
/s/ Quang X. Pham|2026-06-18